Reciprocal interferences of the left ventricular assist device and the aortic valve competence

被引:5
作者
Vriz, Olga [1 ]
Mushtaq, Ali [2 ]
Shaik, Abdullah [2 ]
El-Shaer, Ahmed [2 ]
Feras, Khalid [1 ]
Eltayeb, Abdalla [1 ]
Alsergnai, Hani [1 ]
Kholaif, Naji [1 ]
Al Hussein, Mosaad [1 ]
Albert-Brotons, Dimpna [1 ]
Simon, Andre Rudiger [1 ]
Tsai, Felix Wang [1 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Heart Ctr Dept, Riyadh, Saudi Arabia
[2] Alfaisal Univ, Sch Med, Riyadh, Saudi Arabia
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2023年 / 9卷
关键词
heart transplant; left ventricular assist device (LVAD); aortic regurgitation; transcatheter aortic valve implantation (TAVI); surgical intervention; END-STAGE HEART; CONTINUOUS-FLOW; PULSATILE-FLOW; INTERNATIONAL SOCIETY; INTERMACS ANALYSIS; AMERICAN SOCIETY; BLOOD-FLOW; INSUFFICIENCY; SUPPORT; FAILURE;
D O I
10.3389/fcvm.2022.1094796
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients suffering from end-stage heart failure tend to have high mortality rates. With growing numbers of patients progressing into severe heart failure, the shortage of available donors is a growing concern, with less than 10% of patients undergoing cardiac transplantation (CTx). Fortunately, the use of left ventricular assist devices (LVADs), a variant of mechanical circulatory support has been on the rise in recent years. The expansion of LVADs has led them to be incorporated into a variety of clinical settings, based on the goals of therapy for patients ailing from heart failure. However, with an increase in the use of LVADs, there are a host of complications that arise with it. One such complication is the development and progression of aortic regurgitation (AR) which is noted to adversely influence patient outcomes and compromise pump benefits leading to increased morbidity and mortality. The underlying mechanisms are likely multifactorial and involve the aortic root-aortic valve (AV) complex, as well as the LVAD device, patient, and other factors, all of them alter the physiological mechanics of the heart resulting in AV dysfunction. Thus, it is imperative to screen patients before LVAD implantation for AR, as moderate or greater AR requires a concurrent intervention at the time of LVADs implantation. No current strict guidelines were identified in the literature search on how to actively manage and limit the development and/or progression of AR, due to the limited information. However, some recommendations include medical management by targeting fluid overload and arterial blood pressure, along with adjusting the settings of the LVADs device itself. Surgical interventions are to be considered depending on patient factors, goals of care, and the underlying pathology. These interventions include the closure of the AV, replacement of the valve, and percutaneous approach via percutaneous occluding device or transcatheter aortic valve implantation. In the present review, we describe the interaction between AV and LVAD placement, in terms of patient management and prognosis. Also it is provided a comprehensive echocardiographic strategy for the precise assessment of AV regurgitation severity.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Aortic Valve Pathology in Patients Supported by Continuous-Flow Left Ventricular Assist Device
    Saito, Tomohiro
    Wassilew, Katharina
    Gorodetski, Boris
    Stein, Julia
    Falk, Volkmar
    Krabatsch, Thomas
    Potapov, Evgenij
    CIRCULATION JOURNAL, 2016, 80 (06) : 1371 - 1377
  • [42] Management of Aortic Insufficiency Using Transcatheter Aortic Valve Replacement in Patients with Left Ventricular Assist Device Support
    Kar, Biswajit
    Prathipati, Priyanka
    Jumean, Marwan
    Nathan, Sriram S.
    Gregoric, Igor D.
    ASAIO JOURNAL, 2020, 66 (06) : E82 - E86
  • [43] Transcatheter aortic valve replacement in a patient with severe aortic regurgitation following left ventricular assist device implantation
    Trebacz, Jaroslaw
    Wierzbicki, Karol
    Sobczynski, Robert
    Konstanty-Kalandyk, Janusz
    Stapor, Maciej
    Okarski, Michal
    Kapelak, Boguslaw
    Legutko, Jacek
    Kleczynski, Pawel
    KARDIOLOGIA POLSKA, 2023, 81 (01) : 64 - 65
  • [44] Transcatheter aortic valve replacement: A potential option for aortic insufficiency management in patients with left ventricular assist device
    Mondal, Samhati
    Dawood, Murtaza
    Bandyopadhyay, Dhrubajyoti
    Taylor, Bradley S.
    Tanaka, Kenichi
    Gupta, Anuj
    IJC HEART & VASCULATURE, 2020, 26
  • [45] Transcatheter aortic valve replacement for left ventricular assist device-related aortic regurgitation and prohibitive surgical risk: a case report
    Barragan-Amado, Andres F.
    Manzur Barbur, Maria
    Holguin, Diego
    Obando, Carlos
    Rodriguez-Gonzalez, Maria J.
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2025, 9 (02)
  • [46] Novacor left ventricular assist device inflow valve endocarditis
    Gazzoli, Fabrizio
    Grande, Antonino Massimiliano
    Pagani, Francesco
    Vigano, Mario
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2009, 35 (05) : 910 - 910
  • [47] Late de novo aortic regurgitation with the Jarvik 2000 Flowmaker® left ventricular assist device
    Rossi, Michele
    Serraino, Giuseppe Filiberto
    Jiritano, Federica
    Renzulli, Attilio
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2012, 35 (12) : 1080 - 1082
  • [48] Pooled comparative analysis of transcatheter aortic valve replacement versus surgical aortic valve replacement in patients with left ventricular assist device
    Magouliotis, Dimitrios E.
    Giamouzis, Grigorios
    Athanasiou, Thanos
    Spiliopoulos, Kyriakos
    Briasoulis, Alexandros
    Skoularigis, John
    Triposkiadis, Filippos
    Xanthopoulos, Andrew
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2025, 73 (02) : 125 - 129
  • [49] Transfemoral transcatheter aortic valve replacement with a self-expanding valve for severe aortic regurgitation in a patient with left ventricular assist device
    Rene, A. Garvey
    Desai, Nimesh
    Wald, Joyce
    Rame, Jesus Eduardo
    Frogel, Jonathan K.
    Anwaruddin, Saif
    JOURNAL OF CARDIAC SURGERY, 2017, 32 (11) : 741 - 745
  • [50] Rate of thromboembolic and bleeding events in patients undergoing concomitant aortic valve surgery with left ventricular assist device implantation
    Yalcin, Yunus C.
    Veenis, Jesse F.
    Brugts, Jasper J.
    Antonides, Christiaan F. J.
    Veen, Kevin M.
    Muslem, Rahatullah
    Bekkers, Jos A.
    Gustafsson, Finn
    Tedford, Ryan J.
    Bogers, Ad J. J. C.
    Caliskan, Kadir
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 359 : 39 - 45